Steven Cohen’s Novavax NVAX Stock Holding History

Steven Cohen’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$942K	Buy	100,000 +65,000	+186%	+$582K	﹤0.01%	2875
2026 Q1	$285K	Sell	35,000 -94,000	-73%	-$852K	﹤0.01%	3385
2025 Q4	$867K	Buy	129,000 +14,000	+12%	+$106K	﹤0.01%	2944
2025 Q3	$997K	Sell	115,000 -60,000	-34%	-$467K	﹤0.01%	1696
2025 Q2	$1.1M	Buy	175,000 +50,000	+40%	+$331K	﹤0.01%	1520
2025 Q1	$801K	Buy	+125,000	New	+$1.03M	﹤0.01%	1510
2024 Q4	–	Sell	-155,000	Closed	-$1.96M	–	2332
2024 Q3	$1.96M	Buy	155,000 +35,000	+29%	+$452K	0.01%	1201
2024 Q2	$1.52M	Buy	+120,000	New	+$1.21M	﹤0.01%	1169

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Steven Cohen's NVAX Position: Q2 2026 in Review

Steven Cohen reduced its Novavax (NVAX) stake by 56% in Q2 2026, selling an estimated $7.65M and leaving 664,286 shares worth $6.26M. The position accounts for 0.01% of the portfolio, ranked #1611.

Steven Cohen first reported a position in NVAX in Q1 2015 and has held it in 11 quarters since. The position peaked at $64.7M in Q3 2020. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Steven Cohen held 664,286 shares of Novavax worth $6.26M as of Q2 2026.
Steven Cohen sold 853,925 Novavax shares in Q2 2026, an estimated $7.65M.
Novavax made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1611 holding.
Steven Cohen first reported a position in Novavax in Q1 2015 and has held it in 11 quarters since.
Steven Cohen's Novavax position peaked at $64.7M in Q3 2020.
264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.